CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Biotechnology company Gilead Sciences Inc. on Thursday announced it had received a subpoena from the U.S. Department of Justice related to its marketing and medical education programs for three of its anti-HIV medications.
Gilead issued a statement saying the subpoena requested documents for its medications Truvada, Viread, and Emtriva. Company officials said they intended to comply with the subpoena, which came from the U.S. Attorney's office in San Francisco, and cooperate in any related government investigation. (Reuters)
From our Sponsors
Most Popular
Latest Stories
Donald Trump just spent a week showing us how much he despises children
May 03 2025 5:51 AM
All about the Daughters of Bilitis, the first U.S. lesbian rights group
May 03 2025 5:35 AM
Our favorite 15 destinations from 'Lonely Planet's new LGBTQ+ travel guide
May 02 2025 3:41 PM
Texas man sentenced for shooting trans woman while on bond for murder
May 02 2025 2:54 PM
WV Gov. Morrisey signs bill closing gender-affirming care 'loophole'
May 02 2025 11:24 AM
The 11 sultriest sapphic femmes and lesbians in film and TV history
May 02 2025 8:31 AM
Jill Sobule, 'I Kissed a Girl' singer-songwriter, dies in house fire
May 02 2025 4:57 AM
Boys! Boys! Boys! podcast: A new voice in queer culture
May 01 2025 5:03 PM